<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2017-05-10" version="194">
<accession>P41743</accession>
<accession>D3DNQ4</accession>
<accession>Q8WW06</accession>
<name>KPCI_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein kinase C iota type</fullName>
<ecNumber>2.7.11.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Atypical protein kinase C-lambda/iota</fullName>
<shortName>PRKC-lambda/iota</shortName>
<shortName>aPKC-lambda/iota</shortName>
</alternativeName>
<alternativeName>
<fullName>nPKC-iota</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PRKCI</name>
<name type="synonym">DXS1179E</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="24296" last="24302">
<title>Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells.</title>
<authorList>
<person name="Selbie L.A."/>
<person name="Schmitz-Peiffer C."/>
<person name="Sheng Y."/>
<person name="Biden T.J."/>
</authorList>
<dbReference type="PubMed" id="8226978"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Genomics" volume="26" first="629" last="631">
<title>Human protein kinase C iota gene (PRKCI) is closely linked to the BTK gene in Xq21.3.</title>
<authorList>
<person name="Mazzarella R."/>
<person name="Ciccodicola A."/>
<person name="Esposito T."/>
<person name="Arcucci A."/>
<person name="Migliaccio C."/>
<person name="Jones C."/>
<person name="Schlessinger D."/>
<person name="D'Urso M."/>
<person name="D'Esposito M."/>
</authorList>
<dbReference type="PubMed" id="7607695"/>
<dbReference type="DOI" id="10.1016/0888-7543(95)80190-W"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Teratocarcinoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="105" last="114">
<title>Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo.</title>
<authorList>
<person name="Diaz-Meco M.T."/>
<person name="Municio M.M."/>
<person name="Sanchez P."/>
<person name="Lozano J."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="8524286"/>
<dbReference type="DOI" id="10.1128/MCB.16.1.105"/>
</citation>
<scope>INTERACTION WITH SMG1</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27521" last="27524">
<title>Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis.</title>
<authorList>
<person name="Murray N.R."/>
<person name="Fields A.P."/>
</authorList>
<dbReference type="PubMed" id="9346882"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27521"/>
</citation>
<scope>FUNCTION IN CELL SURVIVAL</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="3069" last="3080">
<title>Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62.</title>
<authorList>
<person name="Sanchez P."/>
<person name="De Carcer G."/>
<person name="Sandoval I.V."/>
<person name="Moscat J."/>
<person name="Diaz-Meco M.T."/>
</authorList>
<dbReference type="PubMed" id="9566925"/>
<dbReference type="DOI" id="10.1128/MCB.18.5.3069"/>
</citation>
<scope>INTERACTION WITH SQSTM1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Cell Death Differ." volume="6" first="753" last="764">
<title>Overexpression of atypical PKC in PC12 cells enhances NGF-responsiveness and survival through an NF-kappaB dependent pathway.</title>
<authorList>
<person name="Wooten M.W."/>
<person name="Seibenhener M.L."/>
<person name="Zhou G."/>
<person name="Vandenplas M.L."/>
<person name="Tan T.H."/>
</authorList>
<dbReference type="PubMed" id="10467349"/>
<dbReference type="DOI" id="10.1038/sj.cdd.4400548"/>
</citation>
<scope>FUNCTION IN CELL SURVIVAL</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3044" last="3053">
<title>The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.</title>
<authorList>
<person name="Sanz L."/>
<person name="Sanchez P."/>
<person name="Lallena M.-J."/>
<person name="Diaz-Meco M.T."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="10356400"/>
<dbReference type="DOI" id="10.1093/emboj/18.11.3044"/>
</citation>
<scope>INTERACTION WITH SQSTM1 AND IKBKB</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="33289" last="33296">
<title>Unique structural and functional properties of the ATP-binding domain of atypical protein kinase C-iota.</title>
<authorList>
<person name="Spitaler M."/>
<person name="Villunger A."/>
<person name="Grunicke H."/>
<person name="Uberall F."/>
</authorList>
<dbReference type="PubMed" id="10906326"/>
<dbReference type="DOI" id="10.1074/jbc.M002742200"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF LYS-274</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Brain Res. Mol. Brain Res." volume="82" first="107" last="113">
<title>Protein kinase C iota protects neural cells against apoptosis induced by amyloid beta-peptide.</title>
<authorList>
<person name="Xie J."/>
<person name="Guo Q."/>
<person name="Zhu H."/>
<person name="Wooten M.W."/>
<person name="Mattson M.P."/>
</authorList>
<dbReference type="PubMed" id="11042363"/>
<dbReference type="DOI" id="10.1016/S0169-328X(00)00187-X"/>
</citation>
<scope>FUNCTION IN CELL SURVIVAL</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Genes Cells" volume="6" first="107" last="119">
<title>Human homologues of the Caenorhabditis elegans cell polarity protein PAR6 as an adaptor that links the small GTPases Rac and Cdc42 to atypical protein kinase C.</title>
<authorList>
<person name="Noda Y."/>
<person name="Takeya R."/>
<person name="Ohno S."/>
<person name="Naito S."/>
<person name="Ito T."/>
<person name="Sumimoto H."/>
</authorList>
<dbReference type="PubMed" id="11260256"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.2001.00404.x"/>
</citation>
<scope>INTERACTION WITH PARD6A; PARD6B AND PARD6G</scope>
<scope>SUBUNIT OF A COMPLEX CONTAINING PARD6B AND CDC42/RAC1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="152" first="1183" last="1196">
<title>Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures.</title>
<authorList>
<person name="Suzuki A."/>
<person name="Yamanaka T."/>
<person name="Hirose T."/>
<person name="Manabe N."/>
<person name="Mizuno K."/>
<person name="Shimizu M."/>
<person name="Akimoto K."/>
<person name="Izumi Y."/>
<person name="Ohnishi T."/>
<person name="Ohno S."/>
</authorList>
<dbReference type="PubMed" id="11257119"/>
<dbReference type="DOI" id="10.1083/jcb.152.6.1183"/>
</citation>
<scope>INTERACTION WITH PARD3 AND PARD6B IN THE TERNARY AKPC/PAR3/PAR6 COMPLEX</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="3334" last="3341">
<title>Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota /lambda and plays a role in microtubule dynamics in the early secretory pathway.</title>
<authorList>
<person name="Tisdale E.J."/>
</authorList>
<dbReference type="PubMed" id="11724794"/>
<dbReference type="DOI" id="10.1074/jbc.M109744200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GAPDH</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="8414" last="8427">
<title>Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.</title>
<authorList>
<person name="Wooten M.W."/>
<person name="Vandenplas M.L."/>
<person name="Seibenhener M.L."/>
<person name="Geetha T."/>
<person name="Diaz-Meco M.T."/>
</authorList>
<dbReference type="PubMed" id="11713277"/>
<dbReference type="DOI" id="10.1128/MCB.21.24.8414-8427.2001"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-265; TYR-280 AND TYR-334</scope>
<scope>MUTAGENESIS OF TYR-265; TYR-280 AND TYR-334</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Cell. Biochem." volume="85" first="42" last="53">
<title>Phosphorylation of tyrosine 256 facilitates nuclear import of atypical protein kinase C.</title>
<authorList>
<person name="White W.O."/>
<person name="Seibenhener M.L."/>
<person name="Wooten M.W."/>
</authorList>
<dbReference type="PubMed" id="11891849"/>
<dbReference type="DOI" id="10.1002/jcb.10101.abs"/>
</citation>
<scope>INTERACTION WITH KPNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-265</scope>
<scope>MUTAGENESIS OF TYR-265</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="307" first="459" last="465">
<title>Centaurin-alpha(1) associates with and is phosphorylated by isoforms of protein kinase C.</title>
<authorList>
<person name="Zemlickova E."/>
<person name="Dubois T."/>
<person name="Kerai P."/>
<person name="Clokie S."/>
<person name="Cronshaw A.D."/>
<person name="Wakefield R.I.D."/>
<person name="Johannes F.-J."/>
<person name="Aitken A."/>
</authorList>
<dbReference type="PubMed" id="12893243"/>
<dbReference type="DOI" id="10.1016/S0006-291X(03)01187-2"/>
</citation>
<scope>INTERACTION WITH ADAP1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Curr. Biol." volume="13" first="734" last="743">
<title>Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity.</title>
<authorList>
<person name="Yamanaka T."/>
<person name="Horikoshi Y."/>
<person name="Sugiyama Y."/>
<person name="Ishiyama C."/>
<person name="Suzuki A."/>
<person name="Hirose T."/>
<person name="Iwamatsu A."/>
<person name="Shinohara A."/>
<person name="Ohno S."/>
</authorList>
<dbReference type="PubMed" id="12725730"/>
<dbReference type="DOI" id="10.1016/S0960-9822(03)00244-6"/>
</citation>
<scope>INTERACTION WITH PARD6B/PAR-6 AND LLGL1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38015" last="38021">
<title>Atypical protein kinase C plays a critical role in protein transport from pre-Golgi intermediates.</title>
<authorList>
<person name="Tisdale E.J."/>
<person name="Wang J."/>
<person name="Silver R.B."/>
<person name="Artalejo C.R."/>
</authorList>
<dbReference type="PubMed" id="12871960"/>
<dbReference type="DOI" id="10.1074/jbc.M305381200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="52524" last="52530">
<title>Rab2 interacts directly with atypical protein kinase C (aPKC) iota/lambda and inhibits aPKCiota/lambda-dependent glyceraldehyde-3-phosphate dehydrogenase phosphorylation.</title>
<authorList>
<person name="Tisdale E.J."/>
</authorList>
<dbReference type="PubMed" id="14570876"/>
<dbReference type="DOI" id="10.1074/jbc.M309343200"/>
</citation>
<scope>INTERACTION WITH RAB2A</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="4161" last="4165">
<title>Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase C.</title>
<authorList>
<person name="Mamidipudi V."/>
<person name="Lin C."/>
<person name="Seibenhener M.L."/>
<person name="Wooten M.W."/>
</authorList>
<dbReference type="PubMed" id="14684752"/>
<dbReference type="DOI" id="10.1074/jbc.C300431200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF IRAK1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="31109" last="31115">
<title>Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.</title>
<authorList>
<person name="Regala R.P."/>
<person name="Weems C."/>
<person name="Jamieson L."/>
<person name="Copland J.A."/>
<person name="Thompson E.A."/>
<person name="Fields A.P."/>
</authorList>
<dbReference type="PubMed" id="15994303"/>
<dbReference type="DOI" id="10.1074/jbc.M505402200"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Tissue Cell" volume="37" first="53" last="58">
<title>Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells.</title>
<authorList>
<person name="Bicaku E."/>
<person name="Patel R."/>
<person name="Acevedo-Duncan M."/>
</authorList>
<dbReference type="PubMed" id="15695176"/>
<dbReference type="DOI" id="10.1016/j.tice.2004.10.004"/>
</citation>
<scope>INTERACTION WITH CDK7</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Biochem. J." volume="399" first="9" last="20">
<title>A WD-FYVE protein binds to the kinases Akt and PKCzeta/lambda.</title>
<authorList>
<person name="Fritzius T."/>
<person name="Burkard G."/>
<person name="Haas E."/>
<person name="Heinrich J."/>
<person name="Schweneker M."/>
<person name="Bosse M."/>
<person name="Zimmermann S."/>
<person name="Frey A.D."/>
<person name="Caelers A."/>
<person name="Bachmann A.S."/>
<person name="Moelling K."/>
</authorList>
<dbReference type="PubMed" id="16792529"/>
<dbReference type="DOI" id="10.1042/BJ20060511"/>
</citation>
<scope>INTERACTION WITH WDFY2</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="8436" last="8442">
<title>Src-dependent protein kinase C iota/lambda (aPKCiota/lambda) tyrosine phosphorylation is required for aPKCiota/lambda association with Rab2 and glyceraldehyde-3-phosphate dehydrogenase on pre-Golgi intermediates.</title>
<authorList>
<person name="Tisdale E.J."/>
<person name="Artalejo C.R."/>
</authorList>
<dbReference type="PubMed" id="16452474"/>
<dbReference type="DOI" id="10.1074/jbc.M513031200"/>
</citation>
<scope>INTERACTION WITH RAB2A AND GADPH</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="FEBS J." volume="274" first="1552" last="1566">
<title>WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Czeta.</title>
<authorList>
<person name="Fritzius T."/>
<person name="Frey A.D."/>
<person name="Schweneker M."/>
<person name="Mayer D."/>
<person name="Moelling K."/>
</authorList>
<dbReference type="PubMed" id="17313651"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2007.05702.x"/>
</citation>
<scope>INTERACTION WITH VAMP2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="J. Cell Sci." volume="121" first="644" last="654">
<title>Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.</title>
<authorList>
<person name="Wald F.A."/>
<person name="Oriolo A.S."/>
<person name="Mashukova A."/>
<person name="Fregien N.L."/>
<person name="Langshaw A.H."/>
<person name="Salas P.J."/>
</authorList>
<dbReference type="PubMed" id="18270268"/>
<dbReference type="DOI" id="10.1242/jcs.016246"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF EZR</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Microvasc. Res." volume="78" first="40" last="44">
<title>Protein kinase C iota mediates lipid-induced apoptosis of human coronary artery endothelial cells.</title>
<authorList>
<person name="Staiger K."/>
<person name="Schatz U."/>
<person name="Staiger H."/>
<person name="Weyrich P."/>
<person name="Haas C."/>
<person name="Guirguis A."/>
<person name="Machicao F."/>
<person name="Haering H.U."/>
<person name="Kellerer M."/>
</authorList>
<dbReference type="PubMed" id="19327373"/>
<dbReference type="DOI" id="10.1016/j.mvr.2009.01.014"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="3597" last="3607">
<title>Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.</title>
<authorList>
<person name="Justilien V."/>
<person name="Fields A.P."/>
</authorList>
<dbReference type="PubMed" id="19617897"/>
<dbReference type="DOI" id="10.1038/onc.2009.217"/>
</citation>
<scope>INTERACTION WITH ECT2 AND PARD6A</scope>
<scope>MUTAGENESIS OF ASP-72</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT PRO-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-7; SER-8 AND THR-9</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="Biochim. Biophys. Acta" volume="1813" first="1190" last="1197">
<title>PKC-? promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.</title>
<authorList>
<person name="Desai S."/>
<person name="Pillai P."/>
<person name="Win-Piazza H."/>
<person name="Acevedo-Duncan M."/>
</authorList>
<dbReference type="PubMed" id="21419810"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2011.03.007"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BAD</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="8149" last="8157">
<title>Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.</title>
<authorList>
<person name="Justilien V."/>
<person name="Jameison L."/>
<person name="Der C.J."/>
<person name="Rossman K.L."/>
<person name="Fields A.P."/>
</authorList>
<dbReference type="PubMed" id="21189248"/>
<dbReference type="DOI" id="10.1074/jbc.M110.196113"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ECT2</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-564</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-564</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="31883" last="31890">
<title>Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5.</title>
<authorList>
<person name="Hirano Y."/>
<person name="Yoshinaga S."/>
<person name="Ogura K."/>
<person name="Yokochi M."/>
<person name="Noda Y."/>
<person name="Sumimoto H."/>
<person name="Inagaki F."/>
</authorList>
<dbReference type="PubMed" id="15143057"/>
<dbReference type="DOI" id="10.1074/jbc.M403092200"/>
</citation>
<scope>STRUCTURE BY NMR OF 25-108</scope>
<scope>INTERACTION WITH SQSTM1 AND MAP2K5</scope>
<scope>MUTAGENESIS OF LYS-29 AND ASP-72</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="9653" last="9661">
<title>Structure of a cell polarity regulator, a complex between atypical PKC and Par6 PB1 domains.</title>
<authorList>
<person name="Hirano Y."/>
<person name="Yoshinaga S."/>
<person name="Takeya R."/>
<person name="Suzuki N.N."/>
<person name="Horiuchi M."/>
<person name="Kohjima M."/>
<person name="Sumimoto H."/>
<person name="Inagaki F."/>
</authorList>
<dbReference type="PubMed" id="15590654"/>
<dbReference type="DOI" id="10.1074/jbc.M409823200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 25-108 IN COMPLEX WITH PARD6A</scope>
<scope>MUTAGENESIS OF ASP-72; GLU-85 AND ARG-91</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="352" first="918" last="931">
<title>Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif.</title>
<authorList>
<person name="Messerschmidt A."/>
<person name="Macieira S."/>
<person name="Velarde M."/>
<person name="Baedeker M."/>
<person name="Benda C."/>
<person name="Jestel A."/>
<person name="Brandstetter H."/>
<person name="Neuefeind T."/>
<person name="Blaesse M."/>
</authorList>
<dbReference type="PubMed" id="16125198"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.07.060"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 233-596</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT THR-412 AND THR-564</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-118 AND CYS-130</scope>
</reference>
<comment type="function">
<text evidence="16 17 18 19 23 26 29 33 39 40 42 43 45 47">Calcium- and diacylglycerol-independent serine/ threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis. In cultured neurons, prevents amyloid beta protein-induced apoptosis by interrupting cell death process at a very early step. In glioblastoma cells, may function downstream of phosphatidylinositol 3-kinase (PI(3)K) and PDPK1 in the promotion of cell survival by phosphorylating and inhibiting the pro-apoptotic factor BAD. Can form a protein complex in non-small cell lung cancer (NSCLC) cells with PARD6A and ECT2 and regulate ECT2 oncogenic activity by phosphorylation, which in turn promotes transformed growth and invasion. In response to nerve growth factor (NGF), acts downstream of SRC to phosphorylate and activate IRAK1, allowing the subsequent activation of NF-kappa-B and neuronal cell survival. Functions in the organization of the apical domain in epithelial cells by phosphorylating EZR. This step is crucial for activation and normal distribution of EZR at the early stages of intestinal epithelial cell differentiation. Forms a protein complex with LLGL1 and PARD6B independently of PARD3 to regulate epithelial cell polarity. Plays a role in microtubule dynamics in the early secretory pathway through interaction with RAB2A and GAPDH and recruitment to vesicular tubular clusters (VTCs). In human coronary artery endothelial cells (HCAEC), is activated by saturated fatty acids and mediates lipid-induced apoptosis.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="10 46">Atypical PKCs (PRKCI and PRKCZ) exhibit an elevated basal enzymatic activity (that may be due to the interaction with SMG1 or SQSTM1) and are not regulated by diacylglycerol, phosphatidylserine, phorbol esters or calcium ions. Two specific sites, Thr-412 (activation loop of the kinase domain) and Thr-564 (turn motif), need to be phosphorylated for its full activation (By similarity). Might also be a target for novel lipid activators that are elevated during nutrient-stimulated insulin secretion.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="18">13.5 uM for ATP (for recombinant purified PRKCI)</KM>
<Vmax evidence="18">7.4 pmol/min/mg enzyme</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="11 16 20 21 23 24 25 27 28 30 31 32 35 36 37 41 46 48 49">Forms a complex with SQSTM1 and MP2K5 (By similarity). Interacts directly with SQSTM1 (Probable). Interacts with IKBKB. Interacts with PARD6A, PARD6B and PARD6G. Part of a quaternary complex containing aPKC, PARD3, a PARD6 protein (PARD6A, PARD6B or PARD6G) and a GTPase protein (CDC42 or RAC1). Part of a complex with LLGL1 and PARD6B. Interacts with ADAP1/CENTA1. Interaction with SMG1, through the ZN-finger domain, activates the kinase activity. Interacts with CDK7. Forms a complex with RAB2A and GAPDH involved in recruitment onto the membrane of vesicular tubular clusters (VTCs). Interacts with ECT2 ('Thr-359' phosphorylated form). Interacts with VAMP2 (PubMed:17313651). Interacts with WDFY2 (via WD repeats 1-3) (PubMed:16792529).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-81752">
<id>P60953</id>
<label>CDC42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-1057285">
<id>P78545</id>
<label>ELF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-302319">
<id>Q96L34</id>
<label>MARK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-81968">
<id>Q8TEW0</id>
<label>PARD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-81876">
<id>Q9NPB6</id>
<label>PARD6A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-10693102">
<id>Q9NPB6-2</id>
<label>PARD6A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-295391">
<id>Q9BYG5</id>
<label>PARD6B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-295417">
<id>Q9BYG4</id>
<label>PARD6G</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-302345">
<id>Q8ND90</id>
<label>PNMA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-295351">
<id>Q05513</id>
<label>PRKCZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-413628">
<id>P63000</id>
<label>RAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-6124081">
<id>P48431</id>
<label>SOX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-307104">
<id>Q13501</id>
<label>SQSTM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-286199"/>
<interactant intactId="EBI-306940">
<id>Q04917</id>
<label>YWHAH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24 32 48">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="48">Endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24 32">Nucleus</location>
</subcellularLocation>
<text evidence="32 48">Transported into the endosome through interaction with SQSTM1/p62. After phosphorylation by SRC, transported into the nucleus through interaction with KPNB1. Colocalizes with CDK7 in the cytoplasm and nucleus. Transported to vesicular tubular clusters (VTCs) through interaction with RAB2A.</text>
</comment>
<comment type="tissue specificity">
<text evidence="33 44 45">Predominantly expressed in lung and brain, but also expressed at lower levels in many tissues including pancreatic islets. Highly expressed in non-small cell lung cancers.</text>
</comment>
<comment type="domain">
<text evidence="10">The PB1 domain mediates interaction with SQSTM1.</text>
</comment>
<comment type="domain">
<text>The C1 zinc finger does not bind diacylglycerol (DAG).</text>
</comment>
<comment type="domain">
<text evidence="10">The pseudosubstrate motif resembles the sequence around sites phosphorylated on target proteins, except the presence of a non-phosphorylatable residue in place of Ser, it modulates activity by competing with substrates.</text>
</comment>
<comment type="PTM">
<text evidence="10 22 24 34 35">Phosphorylation at Thr-412 in the activation loop is not mandatory for activation (By similarity). Upon neuronal growth factor (NGF) stimulation, phosphorylated by SRC at Tyr-265, Tyr-280 and Tyr-334. Phosphorylation at Tyr-265 facilitates binding to KPNB1/importin-beta regulating entry of PRKCI into the nucleus. Phosphorylation on Tyr-334 is important for NF-kappa-B stimulation.</text>
</comment>
<comment type="similarity">
<text evidence="49">Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.</text>
</comment>
<comment type="sequence caution" evidence="49">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA60171" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="49">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAB17011" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="49">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH22016" version="3"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PRKCIID41857ch3q26.html"/>
</comment>
<dbReference type="EC" id="2.7.11.13"/>
<dbReference type="EMBL" id="L18964">
<property type="protein sequence ID" value="AAA60171.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L33881">
<property type="protein sequence ID" value="AAB17011.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW78513.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW78515.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC022016">
<property type="protein sequence ID" value="AAH22016.3"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3212.2"/>
<dbReference type="PIR" id="A49509">
<property type="entry name" value="A49509"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002731.4">
<property type="nucleotide sequence ID" value="NM_002740.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.478199"/>
<dbReference type="PDB" id="1VD2">
<property type="method" value="NMR"/>
<property type="chains" value="A=25-108"/>
</dbReference>
<dbReference type="PDB" id="1WMH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=25-108"/>
</dbReference>
<dbReference type="PDB" id="1ZRZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=233-596"/>
</dbReference>
<dbReference type="PDB" id="3A8W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=249-588"/>
</dbReference>
<dbReference type="PDB" id="3A8X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=249-588"/>
</dbReference>
<dbReference type="PDB" id="3ZH8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A/B/C=248-594"/>
</dbReference>
<dbReference type="PDB" id="5LI1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=248-596"/>
</dbReference>
<dbReference type="PDB" id="5LI9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=248-596"/>
</dbReference>
<dbReference type="PDB" id="5LIH">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A/B=248-596"/>
</dbReference>
<dbReference type="PDBsum" id="1VD2"/>
<dbReference type="PDBsum" id="1WMH"/>
<dbReference type="PDBsum" id="1ZRZ"/>
<dbReference type="PDBsum" id="3A8W"/>
<dbReference type="PDBsum" id="3A8X"/>
<dbReference type="PDBsum" id="3ZH8"/>
<dbReference type="PDBsum" id="5LI1"/>
<dbReference type="PDBsum" id="5LI9"/>
<dbReference type="PDBsum" id="5LIH"/>
<dbReference type="ProteinModelPortal" id="P41743"/>
<dbReference type="SMR" id="P41743"/>
<dbReference type="BioGrid" id="111570">
<property type="interactions" value="82"/>
</dbReference>
<dbReference type="DIP" id="DIP-31311N"/>
<dbReference type="IntAct" id="P41743">
<property type="interactions" value="55"/>
</dbReference>
<dbReference type="MINT" id="MINT-5004219"/>
<dbReference type="STRING" id="9606.ENSP00000295797"/>
<dbReference type="BindingDB" id="P41743"/>
<dbReference type="ChEMBL" id="CHEMBL2598"/>
<dbReference type="DrugBank" id="DB03777">
<property type="generic name" value="Rbt205 Inhibitor"/>
</dbReference>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1490"/>
<dbReference type="iPTMnet" id="P41743"/>
<dbReference type="PhosphoSitePlus" id="P41743"/>
<dbReference type="BioMuta" id="PRKCI"/>
<dbReference type="DMDM" id="239938658"/>
<dbReference type="EPD" id="P41743"/>
<dbReference type="MaxQB" id="P41743"/>
<dbReference type="PaxDb" id="P41743"/>
<dbReference type="PeptideAtlas" id="P41743"/>
<dbReference type="PRIDE" id="P41743"/>
<dbReference type="DNASU" id="5584"/>
<dbReference type="Ensembl" id="ENST00000295797">
<property type="protein sequence ID" value="ENSP00000295797"/>
<property type="gene ID" value="ENSG00000163558"/>
</dbReference>
<dbReference type="GeneID" id="5584"/>
<dbReference type="KEGG" id="hsa:5584"/>
<dbReference type="UCSC" id="uc003fgs.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5584"/>
<dbReference type="DisGeNET" id="5584"/>
<dbReference type="GeneCards" id="PRKCI"/>
<dbReference type="HGNC" id="HGNC:9404">
<property type="gene designation" value="PRKCI"/>
</dbReference>
<dbReference type="HPA" id="HPA026574"/>
<dbReference type="HPA" id="HPA038635"/>
<dbReference type="MIM" id="600539">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P41743"/>
<dbReference type="OpenTargets" id="ENSG00000163558"/>
<dbReference type="PharmGKB" id="PA33768"/>
<dbReference type="eggNOG" id="KOG0695">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZMG2">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00820000126964"/>
<dbReference type="HOGENOM" id="HOG000233033"/>
<dbReference type="HOVERGEN" id="HBG108317"/>
<dbReference type="InParanoid" id="P41743"/>
<dbReference type="KO" id="K06069"/>
<dbReference type="OMA" id="KLVTVEC"/>
<dbReference type="OrthoDB" id="EOG091G03Q9"/>
<dbReference type="PhylomeDB" id="P41743"/>
<dbReference type="TreeFam" id="TF102004"/>
<dbReference type="BRENDA" id="2.7.11.13">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-209543">
<property type="pathway name" value="p75NTR recruits signalling complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-420029">
<property type="pathway name" value="Tight junction interactions"/>
</dbReference>
<dbReference type="SignaLink" id="P41743"/>
<dbReference type="SIGNOR" id="P41743"/>
<dbReference type="ChiTaRS" id="PRKCI">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P41743"/>
<dbReference type="GeneWiki" id="PRKCI"/>
<dbReference type="GenomeRNAi" id="5584"/>
<dbReference type="PRO" id="PR:P41743"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163558"/>
<dbReference type="CleanEx" id="HS_PRKCI"/>
<dbReference type="Genevisible" id="P41743">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031252">
<property type="term" value="C:cell leading edge"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0045171">
<property type="term" value="C:intercellular bridge"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0015630">
<property type="term" value="C:microtubule cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043220">
<property type="term" value="C:Schmidt-Lanterman incisure"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005543">
<property type="term" value="F:phospholipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004697">
<property type="term" value="F:protein kinase C activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007015">
<property type="term" value="P:actin filament organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070830">
<property type="term" value="P:bicellular tight junction assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045216">
<property type="term" value="P:cell-cell junction organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007010">
<property type="term" value="P:cytoskeleton organization"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035089">
<property type="term" value="P:establishment of apical/basal cell polarity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045197">
<property type="term" value="P:establishment or maintenance of epithelial cell apical/basal polarity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042462">
<property type="term" value="P:eye photoreceptor cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048194">
<property type="term" value="P:Golgi vesicle budding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034351">
<property type="term" value="P:negative regulation of glial cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="WormBase"/>
</dbReference>
<dbReference type="GO" id="GO:2000353">
<property type="term" value="P:positive regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090004">
<property type="term" value="P:positive regulation of establishment of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060252">
<property type="term" value="P:positive regulation of glial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046326">
<property type="term" value="P:positive regulation of glucose import"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006612">
<property type="term" value="P:protein targeting to membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070555">
<property type="term" value="P:response to interleukin-1"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046903">
<property type="term" value="P:secretion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016192">
<property type="term" value="P:vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00029">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd05618">
<property type="entry name" value="STKc_aPKC_iota"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000961">
<property type="entry name" value="AGC-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR034661">
<property type="entry name" value="aPKC_iota"/>
</dbReference>
<dbReference type="InterPro" id="IPR020454">
<property type="entry name" value="DAG/PE-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000270">
<property type="entry name" value="PB1_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002219">
<property type="entry name" value="PE/DAG-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012233">
<property type="entry name" value="PKC"/>
</dbReference>
<dbReference type="InterPro" id="IPR017892">
<property type="entry name" value="Pkinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00130">
<property type="entry name" value="C1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00564">
<property type="entry name" value="PB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00433">
<property type="entry name" value="Pkinase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000554">
<property type="entry name" value="PKC_zeta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00008">
<property type="entry name" value="DAGPEDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00109">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00666">
<property type="entry name" value="PB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00133">
<property type="entry name" value="S_TK_X"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51285">
<property type="entry name" value="AGC_KINASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51745">
<property type="entry name" value="PB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00479">
<property type="entry name" value="ZF_DAG_PE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50081">
<property type="entry name" value="ZF_DAG_PE_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Protein kinase C iota type" id="PRO_0000055710">
<location>
<begin position="2"/>
<end position="596"/>
</location>
</feature>
<feature type="domain" description="PB1" evidence="14">
<location>
<begin position="25"/>
<end position="108"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="254"/>
<end position="522"/>
</location>
</feature>
<feature type="domain" description="AGC-kinase C-terminal">
<location>
<begin position="523"/>
<end position="594"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type" evidence="13">
<location>
<begin position="140"/>
<end position="190"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="260"/>
<end position="268"/>
</location>
</feature>
<feature type="region of interest" description="Regulatory domain">
<location>
<begin position="2"/>
<end position="253"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with RAB2">
<location>
<begin position="2"/>
<end position="28"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PARD6A">
<location>
<begin position="72"/>
<end position="91"/>
</location>
</feature>
<feature type="short sequence motif" description="Pseudosubstrate" evidence="10">
<location>
<begin position="125"/>
<end position="134"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="12 15">
<location>
<position position="378"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="12">
<location>
<position position="283"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylproline" evidence="7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="22 24">
<location>
<position position="265"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="22">
<location>
<position position="280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="22">
<location>
<position position="334"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="50">
<location>
<position position="412"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 9 34">
<location>
<position position="564"/>
</location>
</feature>
<feature type="sequence variant" description="In a metastatic melanoma sample; somatic mutation." id="VAR_042322" evidence="38">
<original>P</original>
<variation>L</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56154494." id="VAR_042323" evidence="38">
<original>R</original>
<variation>C</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with SQSTM1." evidence="30">
<original>K</original>
<variation>A</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with ECT2, PARD6A and with SQSTM1." evidence="30 31 41">
<original>D</original>
<variation>A</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A; when associated with A-91." evidence="31">
<original>E</original>
<variation>A</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A; when associated with A-85." evidence="31">
<original>R</original>
<variation>A</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. Little effect on TRAF6-mediated activation of NF-kappa-B. Decreased binding to KPNB1/importin-beta." evidence="22 24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on activity." evidence="18">
<original>K</original>
<variation>R</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes activity." evidence="18">
<original>K</original>
<variation>W</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. No effect on TRAF6-mediated activation of NF-kappa-B." evidence="22">
<original>Y</original>
<variation>F</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the SRC-mediated phosphorylation state. Significant reduction of SRC-induced enzyme activity. Greatly reduced TRAF6-mediated activation of NF-kappa-B. Reduces NGF-dependent cell survival." evidence="22">
<original>Y</original>
<variation>F</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH22016." ref="4" evidence="49">
<original>L</original>
<variation>M</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH22016." ref="4" evidence="49">
<original>H</original>
<variation>L</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAH22016." ref="4" evidence="49">
<original>P</original>
<variation>R</variation>
<location>
<position position="560"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="26"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="35"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="47"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="73"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="77"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="83"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="101"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="254"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="264"/>
<end position="273"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="274"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="279"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="293"/>
<end position="309"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="318"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="325"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="340"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="352"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="388"/>
<end position="390"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="397"/>
<end position="399"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="422"/>
<end position="425"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="433"/>
<end position="448"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="452"/>
<end position="457"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="467"/>
<end position="476"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="487"/>
<end position="496"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="501"/>
<end position="503"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="505"/>
<end position="507"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="509"/>
<end position="511"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="512"/>
<end position="517"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="527"/>
<end position="531"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="545"/>
<end position="547"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="549"/>
<end position="551"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="554"/>
<end position="557"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="568"/>
<end position="571"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="576"/>
<end position="579"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1VD2"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1WMH"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1ZRZ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3A8X"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZH8"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LI9"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62074"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00226"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01081"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10356400"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10467349"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10906326"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11042363"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11257119"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11260256"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11713277"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11724794"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11891849"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12725730"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12871960"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12893243"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14570876"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684752"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15143057"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590654"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15695176"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15994303"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16125198"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16452474"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16792529"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17313651"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18270268"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19327373"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19617897"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21189248"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21419810"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7607695"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8226978"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8524286"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346882"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9566925"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000305"/>
<evidence key="50" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16125198"/>
</source>
</evidence>
<sequence length="596" mass="68262" checksum="1E3F8C1D4BFC734F" modified="2009-06-16" version="2">
MPTQRDSSTMSHTVAGGGSGDHSHQVRVKAYYRGDIMITHFEPSISFEGLCNEVRDMCSF
DNEQLFTMKWIDEEGDPCTVSSQLELEEAFRLYELNKDSELLIHVFPCVPERPGMPCPGE
DKSIYRRGARRWRKLYCANGHTFQAKRFNRRAHCAICTDRIWGLGRQGYKCINCKLLVHK
KCHKLVTIECGRHSLPQEPVMPMDQSSMHSDHAQTVIPYNPSSHESLDQVGEEKEAMNTR
ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ
TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA
EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYI
APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR
IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK
PNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLLMSAEECV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>